By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



6 rue Alain-Bombard

Saint-Herblain    44800  France
Phone: 33-0-228-073710 Fax: 33-0-228-073711



Company News
Vivalis to Buy Intercell AG in European Biotech Merger for $174 Million 12/17/2012 7:58:56 AM
BioDiem Ltd. (BDM.AX) and Vivalis Begin Collaboration to Test Production of the LAIV Vector on the EB66® Cell Line 5/9/2012 9:20:43 AM
Vivalis and GeoVax Labs Inc. (GOVX.OB) Enter into a Biomanufacturing Agreement for the Production Of MVA-Based Vaccines for HIV 10/18/2011 2:28:55 PM
Potential Treatment for Chikungunya Discovered, A*STAR and Vivalis Reveal 2/28/2011 7:17:34 AM
Potential Treatment for Chikungunya Discovered by Collaboration between Vivalis and A*STAR's Singapore Immunology Network 2/15/2011 9:19:56 AM
Vivalis, GlaxoSmithKline (GSK) Win OK For First Human Trial With EB66 11/24/2010 8:07:20 AM
Vivalis and Kitasato Sign a Research License to Evaluate Eb66(R) Cell Line for Human Viral Vaccine Production 10/12/2010 10:55:03 AM
Vivalis Signs a New Evaluation Agreement for Protein Production in the EB66(R) Cell Line 10/5/2010 11:49:35 AM
Vivalis Signs New Eb66 Research License With MYMETICS Corporation 9/28/2010 11:11:21 AM
Vivalis Publishes Its Results For The First Half And Confirms 2010 Targets 8/31/2010 11:41:07 AM